Role of Denosumab and Zoledronic Acid in Geriatric Hip Fractures – A Comparative Analysis
Background: Osteoporotic hip fractures are on the raise in the world. Denosumab and zoledronic acid are among the commonly used current anti-osteoporotic medications to reduce hip fractures. The purpose of the present study was to compare the effectiveness and adverse events of denosumab and zoled...
Saved in:
| Main Authors: | P Madhuchandra, S Nandeesh, K P Raju |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2024-01-01
|
| Series: | Journal of Surgical Specialties and Rural Practice |
| Subjects: | |
| Online Access: | https://journals.lww.com/jssr/fulltext/2024/05010/role_of_denosumab_and_zoledronic_acid_in_geriatric.5.aspx |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy evaluation of denosumab in the treatment of patients with postmenopausal osteoporosis at high risk of fracture
by: Jing ZHOU, et al.
Published: (2025-02-01) -
Clinical and biochemical efficacy zoledronic acid and denosumab combination: focus serum inflammatory factor level (serum ifcs), bone gla protein (bgp), and bone turnover markers b-collagen degradation product (b-ctx), and procollagen type 1 n-terminal propeptide (p1np)
by: Kong Lingyan, et al.
Published: (2025-01-01) -
Comparative analysis of Denosumab and Zoledronic acid in advanced breast cancer patients receiving CDK4/6 inhibitors
by: Roberta Scafetta, et al.
Published: (2025-08-01) -
Comparison of the effects of zoledronic acid versus denosumab on bone metabolism, inflammatory response, and immunoglobulins in breast cancer patients with bone metastases
by: Zhang Xian, et al.
Published: (2025-01-01) -
A Comparison of the Efficacy and Safety of Denosumab and Zoledronic Acid in Patients with Bone Metastatic Breast Cancer Receiving CDK4/6 Inhibitor Therapy
by: İrem Öner, et al.
Published: (2025-02-01)